ESMO – European Society for Medical Oncology shared on LinkedIn:
“ESMO AI 2026: Real-world data is transforming oncology.
Explore how real-world data is helping researchers and clinicians better understand cancer, improve care pathways, and support innovation across oncology.
Join experts discussing the opportunities, challenges, and future potential of real-world data in oncology during our Educational Session, Monday, 16 November 16:45, featuring:
- Åslaug Helland: Research Director at the OECI-accredited Oslo Comprehensive Cancer Centre and Professor in Oncology
- Miriam Koopman: Professor of Medical Oncology at Utrecht University, whose research focuses on better predicting whether treatment is beneficial for patients with colorectal cancer
- Annelies Verbiest: Medical Oncologist and co-founder and co-chair of the Belgian chapter of Observational Health Data Sciences and Informatics
- Thomas Grinda: Medical oncologist and researcher, Institut Gustave Roussy, France.
Register by 28 October and save!
ESMO AI and Digital Oncology Congress 2026: Registration
Other articles about ESMO AI 2026 on OncoDaily.